Refine by
Assay Articles & Analysis
369 news found
l In Vitro and In Vivo Evaluation of RMT-Targeting Biologics: In vitro BBB models and in vitro assays to assess the BBB transcytosis potential, intracellular trafficking efficiency within the endosomal compartment, and functional efficacy of RMT-targeting biologics; thorough in vivo evaluation services to assess the pharmacokinetics, brain biodistribution, and therapeutic ...
It is favoured for its simplicity, accuracy and low cost. The assay measures the number of colonies formed after exposure to the test chemical. ...
BySTEMart
This comprehensive approach is complemented by multidimensional evaluation using functional assays, transcriptomics and imaging analyses to determine the full impact of CAFs on tumour behaviour. ...
We are proud to introduce Myelotracker®, a peptide-based probe. This unique technology specifically targets lactoferrin, a major protein stored in neutrophil granules, making it possible to visualize and study these immune cells with unmatched precision. Unlike many existing tools, Myelotracker does not activate neutrophils, preserving their natural physiological state and ensuring reliable ...
Cellares is unveiling these partnerships ahead of the 10th Annual CAR-TCR Summit, where it will, for the first time, present drug product release data automatically generated on the Cell Q and case studies highlighting the automation of system verification, thawing, assay preparation, and execution of vector copy number (VCN) quantification. Cell Q is the first of its kind: a ...
The platform covers both linear and conformational epitope analysis and includes the following core services: l Binding Activity Confirmation: ELISA or Western blot assays to verify the interaction between the submitted antibody and antigen. ...
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced release of its new line of Human Hybrid IgM Control Monoclonal Antibodies for research applications, covering a range of diseases such as CMV, HSV, MeV, MuV, RuV, and VZV.Characteristic disease state sera are serum samples derived from individuals with specific ...
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the expansion of its Hepatitis B research portfolio with a comprehensive range of sensitive and specific Hepatitis B Virus Surface Antigen L-proteins. ...
By combining multiple viral vector technologies, including adenovirus, and sophisticated cellular assays, Creative Diagnostics provides validated new drug targets in the antiviral and anti-infective space. ...
In short, the newly implemented behavioral assays will evaluate a spectrum of depression-like symptoms, including anhedonia, social withdrawal, and despair, in animal models for psychiatric research. ...
These exosomes are available in standardized and customizable formats, suitable for use as controls in various experimental procedures, including flow cytometry (FACS), Western blotting (WB), and enzyme-linked immunosorbent assays (ELISA). Joanna, Chief Marketing Officer at Creative Biostructure, stated, "We are excited to broaden our exosome product line to better serve the ...
However, industry and research laboratories face challenges in analyzing complex and diverse samples and require sensitive and reliable drug delivery systems to provide consistent results in support of analytical studies and assays. Since its inception, CD Bioparticles has been committed to developing and providing cutting-edge technologies to advance drug discovery and ...
Endotoxin contamination can interfere with biological assays, leading to inaccurate results and compromising the validity of experiments. ...
” Protheragen’s rare disease diagnostic development services cover in vitro diagnostic (IVD) product development, point-of-care test (POCT) development, laboratory animal models, and companion diagnostic development. By leveraging its expertise in assay development, biomarker identification, and regulatory compliance, Protheragen aims to advance rare disease ...
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is excited to announce the launch of its new line of H5N1 Antibodies and Antigens to support cutting-edge research on this highly pathogenic influenza A virus subtype. ...
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS”, Elizabeth Ratsma, Pre-Registration Clinical Scientist – Cancer Genomics and Charlotte Flanagan, PhD, Innovation Lead, from The Royal Marsden NHS Foundation Trust. ...
Introduction We recently sat down with one of our valued customers, Dr Alexis Rossignol (Clean Cells), to discuss his experience with VIPS PRO, our cutting-edge technology designed to streamline and enhance the early stages of cell line development. This interview provides insight into Clean Cells’ quest to automate and increase single-cell seeding while having undisputable proof ...
SOPHiA GENETICS decentralized MSK-ACCESS®, the highly validated ctDNA assay developed by Memorial Sloan Kettering Cancer Center (MSK), so customers in Europe and worldwide have access to a best-in-class liquid biopsy solution. ...
ECS is the first ecDNA clinical trial assay and was designed by SOPHiA GENETICS in alignment with FDA guidelines as an Investigational Use Only Clinical Trial Assay (IUO CTA). ...
The company’s vaccine development capabilities span delivery system development, assay development, and animal model development. Additionally, its vaccine development services can be tailored according to specific research needs, allowing for precise targeting of the bacteria and stimulating the immune system to generate a robust response against superbugs. ...